VLON News and Press, Vallon Pharmaceuticals Inc. From 02/14/22

- T opline data for p ivotal abuse study of the C ompany’s lead investigational program ADAIR expected this quarter - Second development program, ADMIR, continues to advance with first-in-human ...

Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar for companies due to report. Mond...

– Liv e video webcast presentation on Tuesday, January 25 th at 9:00 AM ET PHILADELPHIA, PA, Jan. 20, 2022 (GLOBE NEWSWIRE) -- Vallon Pharmaceuticals, Inc. (NASDAQ: VLON), (“Vallon” or the “Company”), a clinical-st...

- Survey r esults reinforce existing literature that immediate-release ( IR ) amphetamine s, such as Adderall ® , are the most commonly abused preparation of prescription stimulants - Company’s ...

- Access the event and schedule of presenting companies at virtualinvestorco.com - - Live video webcast presentations of participating companies followed by interactive Q&A session - PITTSTOWN, NJ / ACCESSWIRE / January 12, 2022 / JTC Team ("JTC"), a fully integrate...

PHILADELPHIA, PA, Jan. 04, 2022 (GLOBE NEWSWIRE) -- Vallon Pharmaceuticals, Inc. (NASDAQ: VLON), (“Vallon” or the “Company”), a clinical-stage biopharmaceutical company primarily focused on the development of novel drugs that are designed to deter abuse in th...

- Topline results f ro m p ivotal SEAL study expected in Q1 2022 - If approved, ADAIR will target the growing Adderall ® segment of the ~$9 billion U . S . ADHD market PHILADELPHIA, PA, ...

Palm Beach, FL – December 15, 2021 – FinancialNewsMedia.com News Commentary – Acute Myeloid Leukemia (AML) is a type of blood cancer which usually affects white blood cells (WBCs), however, it can also start in other types of blood-forming cells. In AML, the...

Gainers: American Virtual Cloud Technologies (NASDAQ:AVCT) +50%. Petros Pharmaceuticals (NASDAQ:PTPI) +28%. BioLineRx (NASDAQ:BLRX) +24%. SigmaTron (NASDAQ:SGMA) +20%. Oracle (NYSE:ORCL) +15%. Sprinklr (NYSE:CXM) +15%. Nam Tai Property (NYSE:NTP) +14%. Vasta (NASDAQ:VSTA) +15%. Bottomline Tec...

Gainers: Petros Pharmaceuticals (NASDAQ:PTPI) +37%, Biofrontera BFRI +20%, ABVC BioPharma (NASDAQ:ABVC) +12%, Halozyme Therapeutics (NASDAQ:HALO) +11%, Context Therapeutics CNTX +9%. Losers: Angion Biomedica (NASDAQ:ANGN) -22%, Ensysce Biosciences ...